Yvette Anderson MPS[/caption]
More data needed to tackle costs of cold chain breaches
A pilot study investigating loss of medicines due to cold chain breaches (CCB) in community pharmacies in the Australian Capital Territory (ACT), Australia, has...
Medicinal cannabis: Patient access and clinical evidence
In the August 2017 edition of Australian Pharmacist (page 10), I provided background on the regulatory scheme for cultivation and manufacture of medicinal cannabis,...
How can pharmacists fight waste?
The healthcare sector was recently called out for the devastating levels of waste generated from single-use plastics and medicines. Both hospital and community pharmacists...
Noradrenaline reuptake inhibitors and schizophrenia
Schizophrenia is a chronic illness characterised by a range of symptoms including positive and negative symptoms. Examples of positive symptoms include hallucinations, delusions, and...
Outstanding student wins award at PSA19 Gala Dinner
University of Western Australia student Alice Hashiguchi was awarded the 2019 PSA Mylan Pharmacy Student of the Year (PSOTY) Award last night.
Ms Hashiguchi was...
What does renal pharmacy look like in practice?
Renal expert Carla Scuderi explains the lifelong care journey pharmacists provide to kidney disease patients.
